Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 5, 2011, Pages

  Fang, Jennifer S ^a   Angelov, Stoyan N ^a   Simon, Alexander M ^a   Burt, Janis M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Arteriogenesis; Collateralization; Connexin; Gap junction; Ischemia

Indexed keywords

CONNEXIN 37;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENSITY; EMBRYO DEVELOPMENT; FEMALE; GASTROCNEMIUS MUSCLE; GENE DELETION; GRACILIS FLAP; HYPOTHESIS; LIMB ISCHEMIA; MALE; MICROVASCULAR DENSITY; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; VASCULARIZATION; WILD TYPE;

ANGIOSTATIC PROTEINS; ANIMALS; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; COLLATERAL CIRCULATION; CONNEXINS; DISEASE MODELS, ANIMAL; HINDLIMB; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROVESSELS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PIA MATER; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; TIME FACTORS; X-RAY MICROTOMOGRAPHY;

EID: 80355127952     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00683.2011     Document Type: Article

References (33)

1. Burt JM, Nelson TK, Simon AM, Fang JS. Connexin 37 profoundly slows cell cycle progression in rat insulinoma cells. Am J Physiol Cell Physiol 295: C1103-C1112, 2008.
2. Cai WJ, Kocsis E, Scholz D, Luo X, Schaper W, Schaper J. Presence of Cx37 and lack of desmin in smooth muscle cells are early markers for arteriogenesis. Mol Cell Biochem 262: 17-23, 2004.
3. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics 30: 179-191, 2007.
4. -/- mice. Circulation 99: 3188-3198, 1999.
5. Fang JS, Angelov SN, Simon AM, Burt JM. Cx40 is required for, and Cx37 limits, post-ischemic hindlimb perfusion, survival and recovery. J Vasc Res. In press.
6. Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 18: 330-337, 2008.
7. Figueroa XF, Duling BR. Dissection of two Cx37 independent-conducted vasodilator mechanisms by deletion of Cx40: electrotonic vs regenerative conduction. Am J Physiol Heart Circ Physiol 295: H2001-H2007, 2008.
8. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 83: 636-643, 1998.
9. Good ME, Nelson TK, Simon AM, Burt JM. A functional channel is necessary for growth suppression by Cx37. J Cell Sci 124: 2448-2456, 2011.
10. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 62: 345-356, 2004.
11. Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10: 83-97, 2003.
12. Hirschi KK, Burt JM, Hirschi KD, Dai C. Gap junction communication mediates transforming growth factor-beta activation and endothelial-in-duced mural cell differentiation. Circ Res 93: 429-437, 2003.
13. Kameritsch P, Khandoga N, Nagel W, Hundhausen C, Lidington D, Pohl U. Nitric oxide specifically reduces the permeability of Cx37-containing gap junctions to small molecules. J Cell Physiol 203: 233-242, 2005.
14. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakul-dee W, Makazan J, Tanguy S, Spray DC. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 94: 245-264, 2007.
15. Kirkeby S, Moe D. Binding of Griffonia simplicifolia 1 isolectin B4 (GS1 B4) to a-galactose antigens. Immunol Cell Biol 79: 121-127, 2001.
16. Langille BL, Reidy MA, Kline RL. Injury and repair of endothelium at sites of flow disturbances near abdominal aortic coarctations in rabbits. Arteriosclerosis 6: 146-154, 1986.
17. Larson DM, Wrobleski MJ, Sagar GD, Westphale EM, Beyer EC. Differential regulation of connexin43 and connexin37 in endothelial cells by cell density, growth, and TGF-fj1. Am J Physiol Cell Physiol 272: C405-C415, 1997.
18. Lyon MJ, Steer LM, Malmgren LT. Stereological estimates indicate that aging does not alter the capillary length density in the human posterior cricoarytenoid muscle. J Appl Physiol 103: 1815-1823, 2007.
19. McKinnon RL, Bolon ML, Wang HX, Swarbreck S, Kidder GM, Simon AM, Tyml K. Reduction of electrical coupling between microvascular endothelial cells by NO depends on connexin37. Am J Physiol Heart Circ Physiol 297: H93-H101, 2009.
20. McKinnon RL, Lidington D, Bolon M, Ouellette Y, Kidder GM, Tyml K. Reduced arteriolar conducted vasoconstriction in septic mouse cremas-ter muscle is mediated by nNOS-derived NO. Cardiovasc Res 69: 236-244, 2006.
21. Morel S, Burnier L, Roatti A, Chassot A, Roth I, Sutter E, Galan K, Pfenniger A, Chanson M, Kwak BR. Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. Carcinogenesis 31: 1922-1931, 2010.
22. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
23. Pfenniger A, Derouette JP, Verma V, Lin X, Foglia B, Coombs W, Roth I, Satta N, Dunoyer-Geindre S, Sorgen P, Taffet S, Kwak BR, Delmar M. Gap junction protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells. Arterioscler Thromb Vasc Biol 30: 827-834, 2010.
24. Pries AR, Hopfner M, le Noble F, Dewhirst MW, Secomb TW. The shunt problem: control of functional shunting in normal and tumour vasculature. Nat Rev Cancer 10: 587-593, 2010.
25. Saito T, Krutovskikh V, Marion MJ, Ishak KG, Bennett WP, Yama-saki H. Human hemangiosarcomas have a common polymorphism but no mutations in the connexin37 gene. Int J Cancer 86: 67-70, 2000.
26. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi T. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109: 603-611, 2002.
27. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature 385: 525-529, 1997.
28. Simon AM, McWhorter AR. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251: 206-220, 2002.
29. Sullivan CJ, Doetschman T, Hoying JB. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol 93: 2009-2017, 2002.
30. Sun Q, Chen RR, Shen Y, Mooney DJ, Rajagopalan S, Grossman PM. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 22: 1110-1116, 2005.
31. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93: 662-670, 1994.
32. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383: 725-737, 2002.
33. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 12: 950-954, 2006.